Prof. Gregory Bix, M.D., Ph.D., F.A.H.A., a physician scientist, is the Director of the Clinical Neuroscience Research Center, the Vada Odom Reynolds Chair in Stroke Research, and Professor and Vice Chair of Clinical and Translational Research and academic affairs in the Departments of Neurosurgery and Neurology at Tulane University School of Medicine, New Orleans, LA, USA. Prof. Bix also holds a number of international academic appointments; Professor at the University of Manchester (England), Clinical Senior Lecturer at University of Glasgow (Scotland), Adjunct Professor, Queensland University of Technology (Australia). He is a Fellow of the American Heart Association and has served on a number of prestigious international and national grant, editorial board and meeting committees. He is a productive (~ 100 publications) multi-grant (NIH, AHA, etc.) awarded principal investigator and is an expert in the fields of stroke, dementia, COVID-19 and long covid. In stroke, Prof. Bix has pioneered the study of the pathology and therapeutic potential of the extracellular matrix and its receptors as novel stroke therapies resulting in more than a dozen patents awarded world-wide. Prof. Bix serves on the scientific advisory board of several pharmaceutical companies. Prof. Bix has won many career awards including the recent Spirit of Tulane award and has given more than one hundred invited seminars, lectures and keynote addresses.